StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
15
Publishing Date
2021 - 11 - 16
1
2021 - 07 - 23
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 09
1
2021 - 05 - 24
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 12
1
2021 - 03 - 25
1
2021 - 03 - 19
1
2021 - 03 - 18
1
2021 - 03 - 11
1
Sector
Health services
1
Health technology
15
Tags
N/a
14
People
1
Entities
Abbvie inc.
13
Advaxis, inc.
1
Amgen inc.
14
Applied genetic technologies corporation
51
Arrival
1
Atyr pharma, inc.
2
Biocryst pharmaceuticals, inc.
13
Biomarin pharmaceutical inc.
3
Bristol-myers squibb company
13
Clovis oncology, inc.
1
Eli lilly and company
13
Forward pharma a/s
1
Gilead sciences, inc.
13
Gossamer bio, inc.
1
Hercules capital, inc.
2
Humana inc.
1
Johnson & johnson
1
Nasdaq, inc.
1
Nuvasive, inc.
1
Omeros corporation
13
Otonomy, inc.
117
Penumbra, inc.
1
Pfizer, inc.
13
Regeneron pharmaceuticals, inc.
6
Sanofi
15
Scynexis, inc.
1
Supernus pharmaceuticals, inc.
3
Syros pharmaceuticals, inc.
1
Tuscan holdings corp. ii
1
Ultragenyx pharmaceutical inc.
1
Xeris pharmaceuticals, inc.
10
Symbols
ABBV
211
ABT
251
ALNY
78
ALPMF
70
ALPMY
70
AMGN
170
AMRN
31
AZN
213
AZNCF
173
BAX
45
BDX
34
BHC
30
BIIB
53
BMRN
29
BMY
119
BNTX
167
BSX
25
BY
26
CMXHF
22
FNCTF
49
GILD
64
GLAXF
270
GLPG
36
GLPGF
36
GOOG
32
GOOGL
32
GSK
334
IGMS
37
INCY
121
IPHA
109
IPHYF
81
JNJ
571
KPTI
25
KYMR
29
LLY
335
MDT
45
MOBV
65
MOR
36
MPSYF
33
MRNA
34
NKTR
43
NVO
139
NVS
329
NVSEF
284
OCX
32
PFE
153
PRGO
111
PRVB
283
PTCT
32
RCFA
83
REGN
254
RLYB
31
SNY
4539
SNYNF
3597
TAK
60
TEVJF
224
TMO
43
TXMD
31
VTRS
87
VXRT
33
Exchanges
Nasdaq
15
Nyse
14
Crawled Date
2021 - 11 - 16
1
2021 - 07 - 27
1
2021 - 06 - 24
1
2021 - 06 - 22
1
2021 - 06 - 09
1
2021 - 05 - 25
1
2021 - 05 - 18
1
2021 - 05 - 12
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 13
1
2021 - 03 - 25
1
2021 - 03 - 19
1
2021 - 03 - 18
1
2021 - 03 - 11
1
Crawled Time
00:00
4
10:51
1
12:34
1
13:07
1
13:17
1
13:27
1
13:30
1
14:03
1
14:30
1
15:49
1
17:43
1
18:32
1
Source
www.agtc.com
1
www.biospace.com
1
www.fda.gov
13
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Sanofi
symbols :
Otic
save search
AGTC Appoints Abraham Scaria, Ph.D., as Chief Science Officer
Published:
2021-11-16
(Crawled : 14:30)
- agtc.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-9.46%
|
O:
0.14%
H:
0.0%
C:
0.0%
OTIC
|
$0.077
|
Health Technology
|
-96.48%
|
O:
-1.82%
H:
0.0%
C:
0.0%
AGTC
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-84.0%
|
O:
-1.63%
H:
0.0%
C:
0.0%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-07-23
(Crawled : 00:00)
- fda.gov
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
Email alert
Add to watchlist
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
Email alert
Add to watchlist
SCYX
|
$1.44
2.49%
2.43%
130K
|
Health Technology
|
Email alert
Add to watchlist
OTIC
|
$0.077
|
Health Technology
|
Email alert
Add to watchlist
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-24
(Crawled : 14:03)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-33.42%
|
O:
0.23%
H:
0.52%
C:
0.13%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
234.55%
|
O:
8.21%
H:
1.89%
C:
-0.83%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.02%
|
O:
0.31%
H:
1.15%
C:
0.6%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
45.97%
|
O:
0.37%
H:
1.55%
C:
0.28%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-55.38%
|
O:
0.0%
H:
10.77%
C:
10.77%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.1%
|
O:
0.29%
H:
0.8%
C:
0.17%
OTIC
|
$0.077
|
Health Technology
|
-96.56%
|
O:
-0.89%
H:
3.14%
C:
1.35%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-80.26%
|
O:
0.32%
H:
0.87%
C:
0.26%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
0.17%
|
O:
0.18%
H:
2.2%
C:
0.61%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-73.93%
|
O:
0.06%
H:
0.35%
C:
0.0%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
12.66%
|
O:
0.71%
H:
1.09%
C:
0.22%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-21
(Crawled : 00:00)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-33.01%
|
O:
0.18%
H:
1.54%
C:
1.39%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
232.33%
|
O:
0.25%
H:
2.13%
C:
1.63%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-26.39%
|
O:
0.21%
H:
0.83%
C:
0.33%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
47.11%
|
O:
0.5%
H:
1.37%
C:
0.91%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-57.66%
|
O:
0.24%
H:
0.73%
C:
-4.13%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.41%
|
O:
-0.32%
H:
0.17%
C:
-0.13%
OTIC
|
$0.077
|
Health Technology
|
-96.58%
|
O:
0.0%
H:
3.98%
C:
-1.33%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-79.75%
|
O:
1.39%
H:
0.79%
C:
0.33%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
0.23%
|
O:
0.57%
H:
0.86%
C:
0.54%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-72.12%
|
O:
0.5%
H:
4.88%
C:
4.7%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
12.67%
|
O:
0.4%
H:
0.53%
C:
0.25%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-06-09
(Crawled : 10:51)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-33.08%
|
O:
0.39%
H:
2.15%
C:
2.08%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
229.09%
|
O:
0.29%
H:
2.43%
C:
2.1%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-23.19%
|
O:
0.5%
H:
2.39%
C:
2.16%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
48.13%
|
O:
0.48%
H:
1.36%
C:
0.99%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-55.38%
|
O:
7.18%
H:
4.52%
C:
-4.07%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.06%
|
O:
0.88%
H:
0.74%
C:
0.5%
OTIC
|
$0.077
|
Health Technology
|
-96.75%
|
O:
-0.84%
H:
5.93%
C:
0.42%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-80.76%
|
O:
0.95%
H:
2.0%
C:
0.25%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-1.11%
|
O:
0.09%
H:
2.4%
C:
1.6%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-74.0%
|
O:
0.82%
H:
2.39%
C:
-1.11%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
13.56%
|
O:
0.46%
H:
1.42%
C:
0.67%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-24
(Crawled : 00:00)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-34.92%
|
O:
0.33%
H:
0.15%
C:
-0.67%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
263.37%
|
O:
0.56%
H:
1.3%
C:
0.01%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-27.02%
|
O:
0.33%
H:
1.03%
C:
0.03%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
43.31%
|
O:
0.4%
H:
0.19%
C:
-0.58%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-49.86%
|
O:
-1.15%
H:
1.46%
C:
-4.66%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.97%
|
O:
0.02%
H:
0.3%
C:
-0.3%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
76.99%
|
O:
0.6%
H:
0.0%
C:
-1.82%
OTIC
|
$0.077
|
Health Technology
|
-96.87%
|
O:
1.21%
H:
0.0%
C:
-7.2%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-79.52%
|
O:
0.94%
H:
1.4%
C:
1.06%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-2.89%
|
O:
0.51%
H:
0.2%
C:
-2.42%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-68.04%
|
O:
0.43%
H:
1.44%
C:
-2.16%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
7.14%
|
O:
-0.18%
H:
1.17%
C:
-1.12%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-18
(Crawled : 13:27)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-35.18%
|
O:
0.17%
H:
0.41%
C:
-0.32%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
271.46%
|
O:
-0.27%
H:
0.69%
C:
-0.19%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.25%
|
O:
-0.06%
H:
0.58%
C:
0.28%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
42.36%
|
O:
-0.67%
H:
1.54%
C:
0.95%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-50.0%
|
O:
0.0%
H:
5.46%
C:
3.16%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.44%
|
O:
0.22%
H:
0.1%
C:
-0.26%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
71.24%
|
O:
-0.14%
H:
0.0%
C:
-1.3%
OTIC
|
$0.077
|
Health Technology
|
-96.73%
|
O:
-0.84%
H:
4.63%
C:
1.7%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-82.86%
|
O:
0.06%
H:
1.35%
C:
-0.06%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-3.34%
|
O:
0.49%
H:
0.66%
C:
-0.81%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-69.19%
|
O:
-0.76%
H:
4.91%
C:
0.77%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
6.56%
|
O:
-0.12%
H:
0.4%
C:
-0.48%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-05-12
(Crawled : 17:43)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-33.93%
|
O:
0.23%
H:
1.22%
C:
0.63%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
272.94%
|
O:
0.0%
H:
0.46%
C:
-0.8%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-23.86%
|
O:
0.26%
H:
1.24%
C:
0.16%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
44.84%
|
O:
-0.03%
H:
1.0%
C:
0.1%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-49.12%
|
O:
-2.68%
H:
7.56%
C:
0.05%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-10.88%
|
O:
-0.46%
H:
0.95%
C:
0.12%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
78.94%
|
O:
-0.84%
H:
3.35%
C:
2.04%
OTIC
|
$0.077
|
Health Technology
|
-96.28%
|
O:
1.92%
H:
4.25%
C:
1.42%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-83.45%
|
O:
-1.41%
H:
2.86%
C:
-1.76%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-0.68%
|
O:
-0.7%
H:
1.8%
C:
1.05%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-63.51%
|
O:
-1.98%
H:
6.47%
C:
4.96%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
6.59%
|
O:
-0.35%
H:
0.92%
C:
-0.23%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-04-22
(Crawled : 12:34)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-34.23%
|
O:
-0.13%
H:
0.05%
C:
-2.13%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
280.37%
|
O:
-0.5%
H:
0.67%
C:
-1.55%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-26.22%
|
O:
-0.26%
H:
0.62%
C:
0.26%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
50.19%
|
O:
-0.14%
H:
0.4%
C:
-0.54%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-55.15%
|
O:
0.26%
H:
4.37%
C:
-0.26%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.74%
|
O:
-0.93%
H:
0.27%
C:
0.17%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
77.07%
|
O:
-0.21%
H:
0.0%
C:
-2.96%
OTIC
|
$0.077
|
Health Technology
|
-96.61%
|
O:
0.0%
H:
3.51%
C:
0.88%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-84.06%
|
O:
0.1%
H:
0.31%
C:
-3.03%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-0.04%
|
O:
-0.46%
H:
0.05%
C:
-1.26%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-62.01%
|
O:
-0.34%
H:
8.09%
C:
3.7%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
3.92%
|
O:
-0.48%
H:
0.36%
C:
-0.97%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-04-20
(Crawled : 13:17)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-33.21%
|
O:
-0.46%
H:
1.26%
C:
0.72%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
282.99%
|
O:
0.41%
H:
1.62%
C:
0.11%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-25.41%
|
O:
-0.23%
H:
1.65%
C:
0.96%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
53.22%
|
O:
-0.45%
H:
1.33%
C:
0.84%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-53.35%
|
O:
-0.8%
H:
3.24%
C:
2.97%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-10.65%
|
O:
-0.08%
H:
0.42%
C:
0.42%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
79.48%
|
O:
-0.03%
H:
1.44%
C:
0.97%
OTIC
|
$0.077
|
Health Technology
|
-96.68%
|
O:
0.0%
H:
0.86%
C:
-1.72%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-83.13%
|
O:
-0.83%
H:
4.52%
C:
3.46%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
1.23%
|
O:
-0.23%
H:
1.22%
C:
0.88%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-61.51%
|
O:
-0.17%
H:
3.22%
C:
-3.31%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
5.06%
|
O:
-0.44%
H:
2.17%
C:
1.69%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-04-12
(Crawled : 00:00)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-28.96%
|
O:
-0.33%
H:
1.52%
C:
1.34%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
293.69%
|
O:
-0.57%
H:
0.28%
C:
-0.88%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-21.85%
|
O:
-0.13%
H:
0.39%
C:
0.26%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
54.74%
|
O:
0.26%
H:
0.7%
C:
0.4%
XERS
|
$1.73
-1.7%
-1.73%
2M
|
Health Technology
|
-58.87%
|
O:
-0.47%
H:
0.12%
C:
-6.65%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-8.8%
|
O:
-0.33%
H:
0.12%
C:
-0.69%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
88.74%
|
O:
1.39%
H:
0.0%
C:
-1.86%
OTIC
|
$0.077
|
Health Technology
|
-96.53%
|
O:
0.0%
H:
0.9%
C:
-0.45%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-83.27%
|
O:
0.0%
H:
0.0%
C:
-7.13%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
2.53%
|
O:
-0.08%
H:
0.08%
C:
-0.61%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-56.61%
|
O:
-0.59%
H:
0.1%
C:
-6.4%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
8.03%
|
O:
-0.17%
H:
0.6%
C:
0.17%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-03-25
(Crawled : 15:49)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-26.99%
|
O:
0.11%
H:
0.39%
C:
0.06%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
303.12%
|
O:
0.46%
H:
1.46%
C:
1.15%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-21.46%
|
O:
1.12%
H:
0.0%
C:
-0.33%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
61.47%
|
O:
-0.16%
H:
1.21%
C:
0.95%
SUPN
|
$29.43
1.94%
1.9%
360K
|
Health Technology
|
16.9%
|
O:
-0.32%
H:
5.23%
C:
4.43%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.63%
|
O:
0.89%
H:
0.5%
C:
0.41%
OTIC
|
$0.077
|
Health Technology
|
-97.09%
|
O:
-1.88%
H:
2.3%
C:
0.0%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-84.32%
|
O:
-1.44%
H:
3.5%
C:
2.24%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
3.75%
|
O:
0.67%
H:
0.15%
C:
-1.22%
BMRN
|
$88.68
-1.54%
-1.57%
1.8M
|
Health Technology
|
18.6%
|
O:
-0.72%
H:
1.06%
C:
0.76%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-57.93%
|
O:
-4.08%
H:
7.03%
C:
6.04%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
9.56%
|
O:
0.64%
H:
0.2%
C:
-0.32%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-03-19
(Crawled : 18:32)
- fda.gov
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
Email alert
Add to watchlist
OTIC
|
$0.077
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
BMRN
|
$88.68
-1.54%
-1.57%
1.8M
|
Health Technology
|
Email alert
Add to watchlist
SUPN
|
$29.43
1.94%
1.9%
360K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
Janux Therapeutics Appoints Vickie Capps and Dr. Sheila Gujrathi to Board of Directors
Published:
2021-03-18
(Crawled : 13:30)
- biospace.com/
HUM
4
|
$328.33
1.08%
0.48%
1.1M
|
Health Services
|
-18.55%
|
O:
-0.26%
H:
2.35%
C:
1.41%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.74%
|
O:
-0.45%
H:
0.7%
C:
0.43%
OTIC
|
$0.077
|
Health Technology
|
-97.35%
|
O:
-1.03%
H:
3.46%
C:
-2.42%
NUVA
|
$39.75
-2.24%
-2.29%
0
|
Health Technology
|
-41.37%
|
O:
0.15%
H:
2.03%
C:
-0.99%
GOSS
4
|
$0.7837
-2.77%
-2.85%
670K
|
Health Technology
|
-92.21%
|
O:
-1.2%
H:
1.42%
C:
-3.84%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
10.1%
|
O:
-1.54%
H:
2.76%
C:
1.63%
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published:
2021-03-11
(Crawled : 13:07)
- fda.gov
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-25.57%
|
O:
0.4%
H:
0.14%
C:
-1.03%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
253.52%
|
O:
0.52%
H:
0.36%
C:
-0.63%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-19.69%
|
O:
0.11%
H:
0.31%
C:
-1.07%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
54.08%
|
O:
0.12%
H:
0.46%
C:
-0.24%
SUPN
|
$29.43
1.94%
1.9%
360K
|
Health Technology
|
14.09%
|
O:
0.12%
H:
3.37%
C:
3.33%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.44%
|
O:
-0.31%
H:
0.63%
C:
0.08%
OTIC
|
$0.077
|
Health Technology
|
-97.21%
|
O:
1.81%
H:
2.48%
C:
1.42%
OMER
|
$3.045
-5.14%
-5.42%
390K
|
Health Technology
|
-84.05%
|
O:
2.46%
H:
1.25%
C:
0.36%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
4.46%
|
O:
-0.63%
H:
0.83%
C:
-0.66%
BMRN
|
$88.68
-1.54%
-1.57%
1.8M
|
Health Technology
|
14.42%
|
O:
0.28%
H:
1.23%
C:
-0.35%
BCRX
|
$4.44
-1.33%
-1.35%
4.7M
|
Health Technology
|
-67.45%
|
O:
1.62%
H:
0.65%
C:
-6.07%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
16.95%
|
O:
0.3%
H:
1.43%
C:
0.22%
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.